Literature DB >> 21089070

Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-PH module of neurofibromin.

Stefan Welti1, Sonja Kühn, Igor D'Angelo, Britta Brügger, Dieter Kaufmann, Klaus Scheffzek.   

Abstract

Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by alterations in the tumor suppressor gene NF1. Clinical manifestations include various neural crest derived tumors, pigmentation anomalies, bone deformations, and learning disabilities. NF1 encodes the Ras specific GTPase activating protein (RasGAP) neurofibromin, of which the central RasGAP related domain as well as a Sec14-like (residues 1560-1699) and a tightly interacting pleckstrin homology (PH)-like (1713-1818) domain are currently well defined. However, patient-derived nontruncating mutations have been reported along the whole NF1 gene, suggesting further essential protein functions. Focusing on the Sec14-PH module, we have engineered such nontruncating mutations and analyzed their implications on protein function and structure using lipid binding assays, CD spectroscopy and X-ray crystallography. Although lipid binding appears to be preserved among most nontruncating mutants, we see major structural changes for two of the alterations. Judging from these changes and our biochemical data, we suggest the presence of an intermolecular contact surface in the lid-lock region of the protein.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21089070     DOI: 10.1002/humu.21405

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

Review 2.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

3.  Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.

Authors:  Eungu Kang; Yoon-Myung Kim; Go Hun Seo; Arum Oh; Hee Mang Yoon; Young-Shin Ra; Eun Key Kim; Heyry Kim; Sun-Hee Heo; Gu-Hwan Kim; Mark J Osborn; Jakub Tolar; Han-Wook Yoo; Beom Hee Lee
Journal:  J Hum Genet       Date:  2019-11-28       Impact factor: 3.172

4.  Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.

Authors:  D Kaufmann; J Hoesch; Y Su; L Deeg; K Mellert; J P Spatz; R Kemkemer
Journal:  Mol Syndromol       Date:  2012-09-27

5.  Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor.

Authors:  Sureshbabu Ram Kumar Pandian; Parasuraman Pavadai; Sivakumar Vellaisamy; Vigneshwaran Ravishankar; Ponnusamy Palanisamy; Lakshmi M Sundar; Vivek Chandramohan; Murugesan Sankaranarayanan; Theivendren Panneerselvam; Selvaraj Kunjiappan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-06       Impact factor: 3.000

6.  Structural basis for p50RhoGAP BCH domain-mediated regulation of Rho inactivation.

Authors:  Vishnu Priyanka Reddy Chichili; Ti Weng Chew; Srihari Shankar; Shi Yin Er; Cheen Fei Chin; Chacko Jobichen; Catherine Qiurong Pan; Yiting Zhou; Foong May Yeong; Boon Chuan Low; J Sivaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

7.  Cross-species analyses identify the BNIP-2 and Cdc42GAP homology (BCH) domain as a distinct functional subclass of the CRAL_TRIO/Sec14 superfamily.

Authors:  Anjali Bansal Gupta; Liang En Wee; Yi Ting Zhou; Michael Hortsch; Boon Chuan Low
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

Review 8.  Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.

Authors:  Jody F Longo; Shannon M Weber; Brittany P Turner-Ivey; Steven L Carroll
Journal:  Adv Anat Pathol       Date:  2018-09       Impact factor: 4.571

9.  Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.

Authors:  Christina Kiel; Luis Serrano
Journal:  Mol Syst Biol       Date:  2014-05-06       Impact factor: 11.429

10.  Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I.

Authors:  Min Xu; Hui Xiong; Yanfang Han; Chijun Li; Shaozhen Mai; Zhongzhou Huang; Xuechen Ai; Zhixuan Guo; Fanqin Zeng; Qing Guo
Journal:  Front Genet       Date:  2018-07-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.